RESEARCH-USE BIOSIMILAR ANTIBODY
Zampilimab
Monoclonal antibody · IgG4
Zampilimab (UCB-7858) is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab inhibits TG2 crosslinking transamidation activity with an IC50 of 0.25 nM and a Kd of <50 pM. Zampilimab improves renal fibrosis.
TARGETTGM2
YMonoclonal antibody
CATALOGSC-BS-025
CATALOG NUMBERSC-BS-025
MOLECULAR WEIGHTApprox. 143.48 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Zampilimab (UCB-7858) is a monoclonal antibody against transglutaminase 2 (TG2). Zampilimab inhibits TG2 crosslinking transamidation activity with an IC50 of 0.25 nM and a Kd of <50 pM. Zampilimab improves renal fibrosis.
Zampilimab is a recombinant research-use antibody directed against TGM2.